Abstract 6332: nELISA high-throughput protein profiling applied to the RADIOHEAD cohort: Insights from the largest plasma proteomics study of patients receiving checkpoint inhibitor therapy
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Parker Institute for Cancer Immunotherapy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148675746
Cites:
Cited by:
Related to:
